nature.com search

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Search
My Account Login

nature
search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (1)

Journal

Check one or more journals to show results from those journals only.

British Journal of Cancer (4)
The Pharmacogenomics Journal (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Cancer (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–5 of 5 results

Loading Filters

Research | 22 March 2016
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab
- F S Falvella
- , C Cremolini
- , R Miceli
- , F Nichetti
- , S Cheli
- , C Antoniotti
- , G Infante
- , A Martinetti
- , F Marmorino
- , E Sottotetti
- , R Berenato
- , M Caporale
- , A Colombo
- , F de Braud
- , M Di Bartolomeo
- , E Clementi
- , F Loupakis
- & F Pietrantonio
The Pharmacogenomics Journal 17 , 331–336

Rights & permissionsfor article Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab . Opens in a new window.
1 April 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
- E Bajetta
- , M Di Bartolomeo
- , C Carnaghi
- , R Buzzoni
- , L Mariani
- , V Gebbia
- , G Comella
- , G Pinotti
- , G Ianniello
- , G Schieppati
- , AM Bochicchio
- & L Maiorino
British Journal of Cancer 77 , 1149–1154

Rights & permissionsfor article FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study . Opens in a new window.
1 May 1995
Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group
- R Buzzoni
- , L Biganzoli
- , E Bajetta
- , L Celio
- , A Fornasiero
- , L Mariani
- , N Zilembo
- , M Di Bartolomeo
- , A Di Leo
- , G Arcangeli
- , E Aitini
- , G Farina
- , G Schieppati
- , D Galluzzo
- & A Martinetti
British Journal of Cancer 71 , 1111–1114

Rights & permissionsfor article Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group . Opens in a new window.
1 October 1995
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor
- N Zilembo
- , C Noberasco
- , E Bajetta
- , A Martinetti
- , L Mariani
- , S Orefice
- , R Buzzoni
- , M Di Bartolomeo
- , A Di Leo
- , A Laffranchi
- & E di Salle
British Journal of Cancer 72 , 1007–1012

Rights & permissionsfor article Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor . Opens in a new window.
23 January 2007 | Open
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
- E Bajetta
- , M Di Bartolomeo
- , R Buzzoni
- , L Mariani
- , N Zilembo
- , E Ferrario
- , S Lo Vullo
- , E Aitini
- , L Isa
- , C Barone
- , S Jacobelli
- , E Recaldin
- , G Pinotti
- & A Iop
British Journal of Cancer 96 , 439–444

Rights & permissionsfor article Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study . Opens in a new window.

Search

Article Search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

Refine your results by…

Filters ​

Filter By:

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

Search

Quick links

Filters